8-K: NRC Health Q1 2026 Results Show Revenue Growth

NRC Health reported first quarter 2026 results with a 4% revenue increase to $34.8 million and a 13% rise in Total Recurring Contract Value (TRCV) to $152.1 million.

Summary

• NRC Health announced its financial and operating results for the first quarter ended March 31, 2026.
• Total revenue for the quarter was $34.8 million, a 4% increase compared to the prior year.
• Total Recurring Contract Value (TRCV) reached $152.1 million, up 13% year-over-year and marking the sixth consecutive quarter of sequential growth.
• GAAP net income was $3.2 million, or $0.14 per diluted share.
• Adjusted Net Income was $4.6 million, or $0.21 per diluted share.
• Adjusted EBITDA was $9.4 million, representing 27% of revenue.
• Net cash flow from operating activities was $7.2 million, and free cash flow was $5.4 million.
• The company declared a quarterly cash dividend of $0.16 per share, payable on July 10, 2026.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a moderately positive report, with clear signs of returning revenue growth and strong contract value, though profitability metrics saw a year-over-year decline.

Positives

• Revenue increased by 4% year-over-year to $34.8 million.
• Total Recurring Contract Value (TRCV) grew 13% year-over-year to $152.1 million, indicating strong future revenue potential.
• TRCV has grown sequentially for six consecutive quarters.
• New sales and customer retention reached multi-year highs.
• The company signed the largest deal in its 45-year history.
• Net cash flow from operating activities increased 8% year-over-year to $7.2 million.
• Free cash flow increased to $5.4 million, representing 15.4% of revenue, up from 10.9% in the prior year.
• The company declared a quarterly cash dividend of $0.16 per share.

Negatives

• GAAP net income decreased from $5.8 million in Q1 2025 to $3.2 million in Q1 2026.
• Adjusted Net Income decreased from $5.9 million in Q1 2025 to $4.6 million in Q1 2026.
• Adjusted EBITDA decreased from $10.3 million in Q1 2025 to $9.4 million in Q1 2026.
• Operating income decreased from $8.6 million in Q1 2025 to $5.6 million in Q1 2026.
• Diluted GAAP EPS decreased from $0.25 in Q1 2025 to $0.14 in Q1 2026.
• Diluted Adjusted EPS decreased from $0.26 in Q1 2025 to $0.21 in Q1 2026.
• Cash and cash equivalents decreased from $4.1 million at the end of 2025 to $2.5 million at the end of Q1 2026.
• Capital expenditures were $1.8 million in Q1 2026, compared to $3.0 million in Q1 2025, indicating a reduction in investment.

Risks

• Risks and uncertainties that may affect future results are detailed in the Company's Annual Report on Form 10-K for the year ended December 31, 2025, and other SEC filings.
• Forward-looking statements are subject to significant risks and uncertainties, and actual results may differ materially from those anticipated.

Future Outlook

The company is committed to evolving from a measurement partner to a true outcomes driver, helping healthcare organizations turn Human Understanding into measurable, repeatable improvement. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially.

Management Comments

• "We delivered a strong start to 2026, with record Total Recurring Contract Value and our first quarter of year-over-year revenue growth since 2023, reflecting the tangible momentum building across our business."
• "The signing of the largest deal in our 45-year history is a powerful validation of our strategy and the differentiated value we deliver to health systems navigating an increasingly complex environment."
• "Our new sales and customer retention both reached multi-year highs this quarter, underscoring the trust our customers place in us."
• "As we look ahead, we remain committed to evolving from a measurement partner to a true outcomes driver, helping healthcare organizations turn Human Understanding into measurable, repeatable improvement."

Industry Context

StockSavvy.ai notes that NRC Health's focus on healthcare experience improvement solutions aligns with the growing industry trend of prioritizing patient and consumer satisfaction as key drivers of success and reimbursement in the healthcare sector. The reported revenue growth and record TRCV suggest the company is capitalizing on this trend.

Comparison to Industry Standards

• The reported revenue growth of 4% for Q1 2026 is modest compared to some high-growth SaaS companies, but within a reasonable range for established healthcare technology providers.
• The Adjusted EBITDA margin of 27% is strong and generally above the average for many software and service companies, indicating efficient operations.
• The increase in TRCV by 13% is a positive indicator of future revenue, which is a key metric for subscription-based businesses in the healthcare IT sector.
• Competitors in the healthcare experience management space include companies like Press Ganey, Healthgrades, and Qualtrics, though direct financial comparisons are difficult without specific filings from those entities.

Stakeholder Impact

• Shareholders: The declaration of a quarterly cash dividend of $0.16 per share provides a direct financial return.
• Customers: Continued investment in healthcare experience improvement solutions aims to deliver greater value and measurable outcomes.
• Employees: Multi-year highs in new sales and customer retention suggest a stable and growing business environment.

Next Steps

• Continue to evolve from a measurement partner to a true outcomes driver.
• Focus on helping healthcare organizations turn Human Understanding into measurable, repeatable improvement.
• Host conference call to discuss financial results on April 28, 2026.

Key Dates

Recommendation

The return to revenue growth and strong TRCV are positive, but the year-over-year decline in profitability metrics and the modest revenue increase warrant a cautious 'hold' rating until sustained improvement is demonstrated.

Keywords

NRC Health, Healthcare Experience, Q1 2026 Results, Revenue Growth, TRCV, Financial Report, Earnings, Healthcare Solutions